Isomorphic Labs raises $5B in Series C, six months after previous round
Isomorphic Labs has raised $5 billion in a Series C financing, following a $2.1 billion round completed only six months earlier. The pace and scale of the two rounds indicate exceptionally strong investor demand for the company.
Multiple biotechnology publications reported that the Series C breaks the record for the largest biotech venture-capital fundraising round. The available reports do not specify the company’s valuation or how the new capital will be deployed.